Physician profile
Jack J Wazen
NPI 1801806757
$16,335.58
in general payments reported to CMS, 2019-2025
12 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,687 · 2020: $402 · 2021: $292 · 2022: $2,554 · 2023: $3,943 · 2024: $3,294 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,200 · Food and Beverage: $1,859 · Travel and Lodging: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,200.00 |
| Food and Beverage | $1,858.69 |
| Travel and Lodging | $341.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $9,988.38 | 2019-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Oticon Medical, LLC | $2,290.07 | 2019-2021 | |
| Med-El Corporation | $1,352.65 | 2019-2025 | Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft |
| Advanced Bionics, LLC | $947.68 | 2019-2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Medical Device Business Services, INC. | $738.78 | 2019 | |
| Acclarent, INC | $563.74 | 2019-2023 | Trudi Nav Cable |
| Merit Medical Systems INC | $161.41 | 2024 | Endomaxx Stent and Delivery System |
| Glaxosmithkline, LLC. | $123.14 | 2024 | Nucala |
| Stryker Corporation | $103.98 | 2019-2022 | |
| Ethicon US, LLC | $29.78 | 2019 | |
| Otonomy, INC. | $20.63 | 2019 | |
| Optinose US, INC. | $15.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Wazen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.